Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-15

Clinical Trial Update: REDAPT Revision Hip System With RSA [NA]

View source ↗

Summary

Clinical trial update for REDAPT Revision Hip System with RSA shows the study is active but not recruiting for osteoarthritis of the hip.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Orthopaedic Innovation Centre | Conditions: Hip Osteoarthritis | NA | Status: ACTIVE_NOT_RECRUITING